Patents by Inventor Joseph F Russo

Joseph F Russo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 7754866
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: July 13, 2010
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • NON-ENDOGENOUS, CONSTITUTIVELY ACTIVATED HUMAN SEROTONIN RECEPTORS AND SMALL MOLECULE MODULATORS THEREOF
    Publication number: 20090076254
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Application
    Filed: March 19, 2008
    Publication date: March 19, 2009
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 7368539
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Grant
    Filed: November 2, 2004
    Date of Patent: May 6, 2008
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 6846919
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: January 25, 2005
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P Behan, Derek T Chalmers, Chen W Liaw, Joseph F Russo, William J Thomsen
  • Non-endogeneous, constitutively activated human serotonin receptors and small molecule modualtors thereof
    Publication number: 20030224442
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Application
    Filed: January 23, 2002
    Publication date: December 4, 2003
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Publication number: 20030153004
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Application
    Filed: June 19, 2002
    Publication date: August 14, 2003
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 6541209
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: April 1, 2003
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 6420541
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT2A receptors.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: July 16, 2002
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, Joseph F. Russo, William J. Thomsen
  • Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
    Patent number: 6150393
    Abstract: Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT.sub.2A and human 5-HT.sub.2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT.sub.2A receptors. Yet further disclosed is a new class of compounds which act at the 5HT.sub.2A receptors.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: November 21, 2000
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Nigel R. A. Beeley, Richard J. Foster, Robert C. Glen, Michael S. Lawless, Chen W. Liaw, Qian Liu, Frederique Menzaghi, Joseph F. Russo, Julian R. Smith, William J. Thomsen
  • Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
    Patent number: 6140509
    Abstract: A compound of formula (C) useful as a serotonin receptor modulator
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: October 31, 2000
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Richard J. Foster, Robert C. Glen, Michael S. Lawless, Chen W. Liaw, Qian Liu, Joseph F. Russo, Julian R. Smith, William J. Thomsen
  • 5-HT2A receptor inverse agonists
    Patent number: 6107324
    Abstract: Disclosed herein is a new class of pyrazole compounds which act at the 5HT.sub.2A receptors.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: August 22, 2000
    Assignees: Arena Pharmaceuticals Inc., Tripos, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Richard J. Foster, Robert C. Glen, Michael S. Lawless, Chen W. Liaw, Qian Liu, Joseph F. Russo, Julian R. Smith, William J. Thomsen